Fig. 63From: 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one (Abstract P166). Anti-NY-ES0-1 specific responses in Cohort 1 are more robust and detected earlier vs Cohort 2. Differences between Cohort 1 and Cohort 2 at each time point are shown for Mean (of cohort) corrected SPW. Asterisks (*) indicate highly significant differencesBack to article page